-

CDISC and DiMe Partner to Advance DHT Data Standards to Improve Health Outcomes

AUSTIN, Texas & BOSTON--(BUSINESS WIRE)--Clinical Data Interchange Standards Consortium (CDISC) and Digital Medicine Society (DiMe) are proud to announce a groundbreaking partnership aimed at enhancing the standardization of digital health technologies (DHTs) data. This partnership will include work with the Digital Health Measurement Collaborative Community (DATAcc) by DiMe, a collaborative community with the FDA’s Center for Devices and Radiological Health as well as other stakeholder communities.

The advantages of DHTs include the ability to collect rich datasets in real-world settings outside of traditional research settings, such as clinics. Further integration of data from DHTs into clinical research supports the development of preventive approaches, harm reduction strategies, and quality therapies to improve health outcomes.

CDISC, globally recognized for its leadership in data standards, and DiMe, a pioneering force in digital medicine, have united to advance use of DHTs in clinical research through the standardization of key concepts, device attributes, endpoints, and best practices to align common resources between both organizations.

“CDISC is grateful for the opportunity to partner with DiMe to further define the digital technology space and to provide enriched resources to support the stakeholder community,” said Dave Evans, CEO at CDISC.

“Our partnership with CDISC is a critical step in unlocking the potential of digital health technology data standards to improve the quality and efficiency of digitally-enabled clinical research,” Jessie Bakker, PhD, Vice President of Digital Measures and Diagnostics at DiMe.

Stakeholders across the digital health and healthcare ecosystem can expect numerous benefits from this collaboration, including enhanced data interoperability and comparability of data across different digital health technologies and applications and accelerated innovation in digital health through shared standards and common semantics.

About CDISC

Clinical Data Interchange Standards Consortium (CDISC) is a global non-profit organization that develops and advances data standards of the highest quality to transform incompatible formats, inconsistent methodologies, and diverse perspectives into a robust framework for generating accessible clinical research data. Driven by the belief that the true measure of data is its impact, CDISC convenes a global community of research experts representing a range of experiences and backgrounds to harness the collective power to drive more meaningful clinical research.

About the Digital Medicine Society

DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs.

Contacts

CDISC
Melissa Kirwin
+1.980.316.8415
mkirwin@cdisc.org

DiMe
Carla English
+1.765.234.3463
press@dimesociety.org

CDISC LogoCDISC Logo

CDISC


Release Versions

Contacts

CDISC
Melissa Kirwin
+1.980.316.8415
mkirwin@cdisc.org

DiMe
Carla English
+1.765.234.3463
press@dimesociety.org

More News From CDISC

ICH and CDISC Collaborate to Support the Maintenance and Governance Process for ICH M11 Controlled Terminology

AUSTIN, Texas & GENEVA--(BUSINESS WIRE)--The International Council for Harmonisation (ICH) M11 Expert Working Group (EWG) (Clinical electronic Structured Harmonized Protocol (CeSHarP) has developed a clinical protocol template and technical specification to ensure clinical study protocols are prepared in a consistent manner and provided to users in a harmonised data exchange format acceptable to all regulatory authorities of the ICH regions. This protocol and electronic exchange format will fac...

Patient Safety Set to Gain as CDISC and UMC Partner to Improve Interoperability of CDISC Standards and WHODrug Global

AUSTIN, Texas & UPPSALA, Sweden--(BUSINESS WIRE)--A new collaboration between two leading organizations in global medical data has been announced to bring greater efficiency and certainty to regulatory bodies, industry, and the healthcare community, ultimately aiming to improve patient safety worldwide. Historically, lack of interoperability has been a significant stumbling block to the effective sharing and use of medicinal product safety data. The strategic partnership announced today takes a...

CDISC is Proud to Announce a Research Collaboration to Incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE)

AUSTIN, Texas--(BUSINESS WIRE)--CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and Research and Office of Regulatory Operations in the Center for Biologics Evaluation and Research to incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE). CDISC’s CORE project provides an open-source version of the CDISC Conformance Rules in a machine-executable format. These rules,...
Back to Newsroom